Evolus Inc . (NASDAQ:EOLS), a company specializing in aesthetic products with a market capitalization of $933 million, has recently made significant strides in expanding its product portfolio and ...
Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
Q4 2024 Earnings Call Transcript February 13, 2025 GE HealthCare Technologies Inc. beats earnings expectations. Reported EPS is $1.45, expectations were $1.26. Operator: Good day, and thank you for ...
Q4 2024 Earnings Call Transcript February 13, 2025 IRadimed Corporation misses on earnings expectations. Reported EPS is ...
Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Here’s a quick look at stocks likely to be in focus in today's trade. Vodafone Idea, Bharti Airtel: The Supreme Court has ...
Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...
Piramal Enterprises Board approved the issuance of secured, rated, listed, and redeemable non-convertible debentures (NCDs) ...
INNOVATE Corp. surged 150% after its subsidiary MediBeacon received FDA approval for its TGFR system. See why I rate VATE ...
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
Q3 2025 Earnings Call Transcript February 13, 2025 Operator: And good day. Thank you for standing by. Welcome to VistaGen ...